rs61746568

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_194248.3(OTOF):​c.145C>T​(p.Arg49Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00455 in 1,613,334 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R49Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0067 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 55 hom. )

Consequence

OTOF
NM_194248.3 missense

Scores

4
10
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 8.07

Publications

23 publications found
Variant links:
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
OTOF Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0154441).
BP6
Variant 2-26527914-G-A is Benign according to our data. Variant chr2-26527914-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48169.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00666 (1014/152312) while in subpopulation AMR AF = 0.0228 (349/15308). AF 95% confidence interval is 0.0208. There are 8 homozygotes in GnomAd4. There are 510 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOFNM_194248.3 linkc.145C>T p.Arg49Trp missense_variant Exon 3 of 47 ENST00000272371.7 NP_919224.1
OTOFNM_001287489.2 linkc.145C>T p.Arg49Trp missense_variant Exon 3 of 46 NP_001274418.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOFENST00000272371.7 linkc.145C>T p.Arg49Trp missense_variant Exon 3 of 47 1 NM_194248.3 ENSP00000272371.2
OTOFENST00000403946.7 linkc.145C>T p.Arg49Trp missense_variant Exon 3 of 46 5 ENSP00000385255.3

Frequencies

GnomAD3 genomes
AF:
0.00668
AC:
1016
AN:
152194
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00811
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0228
Gnomad ASJ
AF:
0.0179
Gnomad EAS
AF:
0.0162
Gnomad SAS
AF:
0.0101
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00171
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.00956
AC:
2403
AN:
251460
AF XY:
0.00857
show subpopulations
Gnomad AFR exome
AF:
0.00812
Gnomad AMR exome
AF:
0.0354
Gnomad ASJ exome
AF:
0.0191
Gnomad EAS exome
AF:
0.0153
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00233
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.00433
AC:
6323
AN:
1461022
Hom.:
55
Cov.:
31
AF XY:
0.00448
AC XY:
3258
AN XY:
726898
show subpopulations
African (AFR)
AF:
0.00721
AC:
241
AN:
33448
American (AMR)
AF:
0.0341
AC:
1527
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
469
AN:
26130
East Asian (EAS)
AF:
0.0199
AC:
788
AN:
39688
South Asian (SAS)
AF:
0.00874
AC:
754
AN:
86234
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53420
Middle Eastern (MID)
AF:
0.0193
AC:
111
AN:
5766
European-Non Finnish (NFE)
AF:
0.00184
AC:
2046
AN:
1111244
Other (OTH)
AF:
0.00639
AC:
386
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
349
698
1047
1396
1745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00666
AC:
1014
AN:
152312
Hom.:
8
Cov.:
32
AF XY:
0.00685
AC XY:
510
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00806
AC:
335
AN:
41556
American (AMR)
AF:
0.0228
AC:
349
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
62
AN:
3472
East Asian (EAS)
AF:
0.0162
AC:
84
AN:
5178
South Asian (SAS)
AF:
0.00993
AC:
48
AN:
4832
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00171
AC:
116
AN:
68024
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
55
110
164
219
274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00424
Hom.:
13
Bravo
AF:
0.00834
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00838
AC:
1017
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.00289
EpiControl
AF:
0.00350

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jan 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 29, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 17, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg49Trp in exon 3 of OTOF: This variant is not expected to have clinical signif icance due to an equal occurrence in Chinese proband chromosomes 2/146 (1.4%) an d ethnically matched control chromosomes 4/184 (2.2%) (Wang 2010). -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 17, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

OTOF: BS1, BS2 -

Jul 26, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 9 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Apr 28, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.070
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.54
D;.
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.97
D;D
MetaRNN
Benign
0.015
T;T
MetaSVM
Uncertain
-0.12
T
MutationAssessor
Uncertain
2.4
M;M
PhyloP100
8.1
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.4
D;D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
1.0
D;.
Vest4
0.86
MVP
0.92
MPC
0.67
ClinPred
0.014
T
GERP RS
5.4
Varity_R
0.47
gMVP
0.63
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61746568; hg19: chr2-26750782; COSMIC: COSV104551959; API